SCHEMBL1506633

SCHEMBL1506633

CCCCCCCCCCCCCCC(O)C(O)=C(O)C(=O)O

nearest known ligand 0.64

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
GPR84 Q9NQS5 7/20 0.64
FFAR1 O14842 2/20 0.64
FFAR4 Q5NUL3 1/20 0.48
MAPT P10636 1/20 0.47
LCK P06239 1/20 0.47
PPARD Q03181 1/20 0.47
ZDHHC20 Q5W0Z9 1/20 0.47
ZDHHC2 Q9UIJ5 1/20 0.47
ACE2 Q9BYF1 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1506632 1.00 GPR84 (0.64) GPR84FFAR1FFAR4MAPTLCK
SCHEMBL28337079 0.83 GPR84 (0.58) GPR84FFAR1FFAR4MAPTLCK
SCHEMBL3989518 0.82 GPR84 (0.56) GPR84FFAR1FFAR4MAPTLCK
SCHEMBL11452262 0.79 GPR84 (0.69) GPR84FFAR1FFAR4MAPTLCK
SCHEMBL28916782 0.79 GPR84 (0.69) GPR84FFAR1FFAR4MAPTLCK
SCHEMBL2709599 0.79 GPR84 (1.00) GPR84FFAR1FFAR4MAPTLCK
SCHEMBL22842 0.79 GPR84 (1.00) GPR84FFAR1FFAR4MAPTLCK
SCHEMBL525619 0.79 GPR84 (1.00) GPR84FFAR1FFAR4MAPTLCK
SCHEMBL524494 0.79 GPR84 (1.00) GPR84FFAR1FFAR4MAPTLCK
SCHEMBL2933185 0.79 GPR84 (1.00) GPR84FFAR1FFAR4MAPTLCK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 83 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260130370-A1 PLANT ACTIVATOR IBIDEN CO., LTD. (JP) 2026-05-14 US claimed
WO-2023212353-A1 VIRAL ENTRY INHIBITORS DERIVED FROM BOTANICALS EMORY UNIVERSITY (US) 2023-11-02 WO claimed
WO-2023146984-A1 LYMPH-RELEASING COMPOSITIONS OF FATTY ACIDS AND USES THEREOF FOR LYMPHATIC INCORPORATION AND SYSTEMIC DISEASE TREATMENT AMARIN PHARMACEUTICALS IRELAND LIMITED (IE) 2023-08-03 WO claimed
EP-3810778-A1 MULTIFUNCTIONAL FATTY ACID DERIVATIVES AND BIOSYNTHESIS THEREOF Genomatica, Inc. (US) 2021-04-28 EP claimed
WO-2019217226-A1 MULTIFUNCTIONAL FATTY ACID DERIVATIVES AND BIOSYNTHESIS THEREOF REG Life Sciences, LLC (US) 2019-11-14 WO claimed
US-20190033313-A1 METHODS AND SYSTEMS FOR DETECTING MELANOMA UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. 2019-01-31 US claimed
US-20180271046-A1 BARLEY LIPOXYGENASE 1 GENE, METHOD OF SELECTING BARLEY VARIETY, MATERIAL OF MALT ALCOHOLIC DRINKS AND PROCESS FOR PRODUCING MALT ALCOHOLIC DRINK SAPPORO BREWERIES LIMITED (JP) 2018-09-27 US claimed
US-20170295738-A1 BARLEY LIPOXYGENASE 1 GENE, METHOD OF SELECTING BARLEY VARIETY, MATERIAL OF MALT ALCOHOLIC DRINKS AND PROCESS FOR PRODUCING MALT ALCOHOLIC DRINK SAPPORO BREWERIES LIMITED (JP) 2017-10-19 US claimed
WO-2016196743-A1 METHODS AND SYSTEMS FOR DETECTING MELANOMA THE UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) 2016-12-08 WO claimed
US-20160017104-A1 Benzene Polycarboxylic Acid Compounds and Their Use as Drug RDINNOVATION APS (DK) 2016-01-21 US claimed
EP-2831151-A1 BENZENE POLYCARBOXYLIC ACID COMPOUNDS AND THEIR USE AS DRUG RDInnovation ApS (DK) 2015-02-04 EP claimed
CN-104245800-A Novel benzene polycarboxylic acid compound RD INNOVATION APS 2014-12-24 CN claimed
WO-2013143549-A1 BENZENE POLYCARBOXYLIC ACID COMPOUNDS AND THEIR USE AS DRUG RDINNOVATION APS (DK) 2013-10-03 WO claimed
US-20130129862-A1 BARLEY LIPOXYGENASE 1 GENE, METHOD OF SELECTING BARLEY VARIETY, MATERIAL OF MALT ALCOHOLIC DRINKS AND PROCESS FOR PRODUCING MALT ALCOHOLIC DRINK SAPPORO BREWERIES LIMITED (JP) 2013-05-23 US claimed
US-20090285932-A1 BARLEY LIPOXYGENASE 1 GENE, METHOD OF SELECTING BARLEY VARIETY, MATERIAL OF MALT ALCOHOLIC DRINKS AND PROCESS FOR PRODUCING MALT ALCOHOLIC DRINK SAPPORO BREWERIES LIMITED (JP) 2009-11-19 US claimed
US-20260130370-A1 PLANT ACTIVATOR IBIDEN CO., LTD. (JP) 2026-05-14 US disclosed
WO-2025094894-A1 PLANT ACTIVATOR イビデン株式会社 2025-05-08 WO disclosed
US-4950688-A CONTROLLING SKIN BARRIER FUNCTION; HYDROXY FATTY ACID OR ESTER CONOPCO, INC. (US) 1990-08-21 US disclosed
EP-0097059-B1 SKIN TREATMENT COMPOSITIONS UNILEVER N.V. (NL) 1989-10-25 EP disclosed
EP-0097059-A2 Skin treatment compositions UNILEVER N.V. (NL) 1983-12-28 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260130370-A1 PLANT ACTIVATOR HAO2, EBP, HAO1 GPR84 833/4885FFAR1 44/4885FFAR4 193/4885
US-20160017104-A1 Benzene Polycarboxylic Acid Compounds and Their Use as Drug PAH, HPD, PLOD2 GPR84 2203/4885FFAR1 1709/4885FFAR4 1870/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.